Preclinical data show potential of CD46-targeted combination therapy in prostate cancer | Urology...
Robert Flavell, MD, PhD, and Anil P. Bidkar, PhD, discuss the synergistic potential of CD46-directed alpha radiation and ADC therapy combination.
urologytimes.com